– Tetra Pharm Technologies y Glysious anuncian una colaboración para desarrollar fármacos combinados transdérmicos dirigidos al sistema endocannabinoide La colaboración aúna la experiencia de Tetra Pharm Technologies en tecnología de capacitación con el sistema patentado de administración…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.